Schlachter; Stephen T.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Schlachter; Stephen T..The latest application filed is for "hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors".
Company Profile
8.39.38
- Schlachter; Stephen T. - Boulder CO
- Schlachter; Stephen T. - Dallas TX
- - Boulder CO US
- Schlachter; Stephen T. - Bouler CO
- Schlachter; Stephen T. - Kalamazoo MI
Patent Activity
| Patent | Date |
|---|---|
| Hydroxylated And Methoxylated Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20220226326 - Mitchell; Ian S. ; et al. | 2022-07-21 |
| Hydroxylated And Methoxylated Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20200345735 - Mitchell; Ian S. ; et al. | 2020-11-05 |
| Aromatic compounds and uses thereof Grant 10,807,948 - Dixon , et al. October 20, 2 | 2020-10-20 |
| Aryl Ethers And Uses Thereof App 20200190031 - Dixon; Darryl David ; et al. | 2020-06-18 |
| Aryl ethers and uses thereof Grant 10,597,366 - Dixon , et al. | 2020-03-24 |
| Aryl Ethers And Uses Thereof App 20190119214 - Dixon; Darryl David ; et al. | 2019-04-25 |
| Compositions for Use in Treating Pulmonary Arterial Hypertension App 20190015377 - Dixon; Darryl David ; et al. | 2019-01-17 |
| Aryl ethers and uses thereof Grant 10,144,711 - Dixon , et al. De | 2018-12-04 |
| Benzimidazole derivatives and uses thereof Grant 10,040,767 - Dixon , et al. August 7, 2 | 2018-08-07 |
| Hydroxylated And Methoxylated Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20180169099 - Mitchell; Ian S. ; et al. | 2018-06-21 |
| Aromatic Compounds And Uses Thereof App 20180162807 - DIXON; Darryl David ; et al. | 2018-06-14 |
| Aryl Ethers And Uses Thereof App 20180155279 - Dixon; Darryl David ; et al. | 2018-06-07 |
| Aryl ethers and uses thereof Grant 9,969,689 - Dixon , et al. May 15, 2 | 2018-05-15 |
| Aryl ethers and uses thereof Grant 9,908,845 - Dixon , et al. March 6, 2 | 2018-03-06 |
| Aryl ethers and uses thereof Grant 9,896,418 - Dixon , et al. February 20, 2 | 2018-02-20 |
| Cyclic sulfone and sulfoximine analogs and uses thereof Grant 9,884,843 - Dixon , et al. February 6, 2 | 2018-02-06 |
| Aryl Ethers And Uses Thereof App 20170217892 - Dixon; Darryl David ; et al. | 2017-08-03 |
| Aryl Ethers And Uses Thereof App 20170217891 - Dixon; Darryl David ; et al. | 2017-08-03 |
| Benzimidazole Derivatives And Uses Thereof App 20170088523 - DIXON; Darryl David ; et al. | 2017-03-30 |
| Cyclic Sulfone And Sulfoximine Analogs And Uses Thereof App 20160368893 - DIXON; Darryl David ; et al. | 2016-12-22 |
| Aryl Ethers And Uses Thereof App 20160251307 - DIXON; Darryl David ; et al. | 2016-09-01 |
| Hydroxylated And Methoxylated Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20160235754 - Mitchell; Ian S. ; et al. | 2016-08-18 |
| Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 9,409,886 - Bencsik , et al. August 9, 2 | 2016-08-09 |
| Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors Grant 9,359,340 - Mitchell , et al. June 7, 2 | 2016-06-07 |
| Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20160152601 - Bencsik; Josef ; et al. | 2016-06-02 |
| Hydroxylated And Methoxylated Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20160152606 - Mitchell; Ian S. ; et al. | 2016-06-02 |
| 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors Grant 9,328,091 - Leivers , et al. May 3, 2 | 2016-05-03 |
| 5H-CYCLOPENTA[d]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS App 20150266852 - Leivers; Anna ; et al. | 2015-09-24 |
| Triazolopyridine compounds as PIM kinase inhibitors Grant 8,987,251 - Allen , et al. March 24, 2 | 2015-03-24 |
| 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors Grant 8,895,566 - Banka , et al. November 25, 2 | 2014-11-25 |
| Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 8,853,199 - Mitchell , et al. October 7, 2 | 2014-10-07 |
| Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 8,846,681 - Mitchell , et al. September 30, 2 | 2014-09-30 |
| 5,7-substituted-imidazo[1,2-c]pyrimidines App 20140228349 - Boys; Mark Laurence ; et al. | 2014-08-14 |
| Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20140080829 - Bencsik; Josef ; et al. | 2014-03-20 |
| Triazolopyridine Compounds As Pim Kinase Inhibitors App 20140045817 - Allen; Shelley ; et al. | 2014-02-13 |
| Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 8,618,097 - Bencsik , et al. December 31, 2 | 2013-12-31 |
| Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 08618097 - | 2013-12-31 |
| Triazolopyridine compounds as PIM kinase inhibitors Grant 8,575,145 - Allen , et al. November 5, 2 | 2013-11-05 |
| 5h-cyclopenta[d]pyrimidines As Akt Protein Kinase Inhibitors App 20130085135 - Banka; Anna ; et al. | 2013-04-04 |
| Xanthones, thioxanthones and acridinones as DNA-PK inhibitors Grant 8,404,681 - Halbrook , et al. March 26, 2 | 2013-03-26 |
| 5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors Grant 8,329,709 - Banka , et al. December 11, 2 | 2012-12-11 |
| Hydroxylated And Methoxylated Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20120232055 - MITCHELL; Ian S. ; et al. | 2012-09-13 |
| Materials and methods to potentiate cancer treatment Grant 8,242,115 - Halbrook , et al. August 14, 2 | 2012-08-14 |
| Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors Grant 8,138,181 - Allen , et al. March 20, 2 | 2012-03-20 |
| Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 8,063,050 - Mitchell , et al. November 22, 2 | 2011-11-22 |
| 5h-cyclopenta[d]pyrimidines As Akt Protein Kinase Inhibitors App 20110251181 - Banka; Anna ; et al. | 2011-10-13 |
| Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20110245230 - Mitchell; Ian S. ; et al. | 2011-10-06 |
| Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 8,003,651 - Mitchell , et al. August 23, 2 | 2011-08-23 |
| Imidazo[1,2-a]Pyridine Compounds As Receptor Tyrosine Kinase Inhibitors App 20110184013 - Allen; Shelley ; et al. | 2011-07-28 |
| Triazolopyridine Compounds As Pim Kinase Inhibitors App 20110144085 - Allen; Shelley ; et al. | 2011-06-16 |
| Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20110015204 - Bencsik; Josef ; et al. | 2011-01-20 |
| Imidazo[1,2-a]pyridine Compounds As Receptor Tyrosine Kinase Inhibitors App 20100029633 - Allen; Shelley ; et al. | 2010-02-04 |
| Materials and methods to potentiate cancer treatment App 20080090782 - Halbrook; James ; et al. | 2008-04-17 |
| Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20080058327 - Mitchell; Ian S. ; et al. | 2008-03-06 |
| Hydroxylated And Methoxylated Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20080051399 - Mitchell; Ian S. ; et al. | 2008-02-28 |
| Xanthones, thioxanthones and acridinones as dna-pk inhibitors App 20070167441 - Halbrook; James W. ; et al. | 2007-07-19 |
| Materials and methods to potentiate cancer treatment Grant 7,179,912 - Halbrook , et al. February 20, 2 | 2007-02-20 |
| Cyclic AMP-specific phosphodiesterase inhibitors Grant 7,176,229 - Martins , et al. February 13, 2 | 2007-02-13 |
| Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases App 20060160838 - Schlachter; Stephen T. ; et al. | 2006-07-20 |
| Cyclic AMP-specific phosphodiesterase inhibitors App 20060074123 - Martins; Timothy J. ; et al. | 2006-04-06 |
| Cyclic AMP-specific phosphodiesterase inhibitors Grant 6,998,416 - Martins , et al. February 14, 2 | 2006-02-14 |
| Cyclic AMP-specific phosphodiesterase inhibitors App 20040152754 - Martins, Timothy J. ; et al. | 2004-08-05 |
| Cyclic AMP-specific phosphodie sterase inhibitors Grant 6,716,871 - Martins , et al. April 6, 2 | 2004-04-06 |
| Cyclic Amp-specific Phosphodiesterase Inhibitors App 20040023945 - Martins, Timothy J. ; et al. | 2004-02-05 |
| Cyclic AMP-specific phosphodiesterase inhibitors Grant 6,680,336 - Martins , et al. January 20, 2 | 2004-01-20 |
| Materials and methods to potentiate cancer treatment App 20020165218 - Halbrook, James ; et al. | 2002-11-07 |
| Substituted pyridine compounds and methods of use Grant 6,458,813 - Mantlo , et al. October 1, 2 | 2002-10-01 |
| Cyclic AMP-specific phosphodiesterase inhibitors Grant 6,423,710 - Martins , et al. July 23, 2 | 2002-07-23 |
| Cyclic AMP-specific phosphodiesterase inhibitors Grant 6,376,489 - Martins , et al. April 23, 2 | 2002-04-23 |
| Substituted pyridine compounds and methods of use App 20020035094 - Mantlo, Nathan B. ; et al. | 2002-03-21 |
| Substituted pyridine compounds and methods of use Grant 6,333,341 - Mantlo , et al. December 25, 2 | 2001-12-25 |
| Substituted pyridine compounds and methods of use Grant 6,022,884 - Mantlo , et al. February 8, 2 | 2000-02-08 |
| Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories Grant 5,397,774 - Nugent , et al. March 14, 1 | 1995-03-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 